-DOCSTART- -X- O
We -X- _ O
compared -X- _ O
the -X- _ O
prevalence -X- _ O
of -X- _ O
8 -X- _ B-Intervention
polymorphisms -X- _ I-Intervention
in -X- _ I-Intervention
the -X- _ I-Intervention
tumor -X- _ I-Intervention
necrosis -X- _ I-Intervention
factor -X- _ I-Intervention
and -X- _ I-Intervention
mannose- -X- _ I-Intervention
binding -X- _ I-Intervention
lectin -X- _ I-Intervention
genes -X- _ I-Intervention
among -X- _ O
105 -X- _ B-Patient
children -X- _ I-Patient
and -X- _ I-Patient
young -X- _ I-Patient
adults -X- _ I-Patient
with -X- _ I-Patient
fatal -X- _ I-Patient
influenza -X- _ I-Patient
with -X- _ O
US -X- _ O
population -X- _ O
estimates -X- _ O
and -X- _ O
determined -X- _ O
in -X- _ O
subanalyses -X- _ O
whether -X- _ O
these -X- _ O
polymorphisms -X- _ B-Intervention
were -X- _ O
associated -X- _ O
with -X- _ O
sudden -X- _ B-Patient
death -X- _ I-Patient
and -X- _ I-Patient
bacterial -X- _ I-Patient
co-infection -X- _ I-Patient
among -X- _ I-Patient
persons -X- _ I-Patient
with -X- _ I-Patient
fatal -X- _ I-Patient
influenza. -X- _ I-Patient
No -X- _ B-Outcome
differences -X- _ I-Outcome
were -X- _ I-Outcome
observed -X- _ I-Outcome
in -X- _ I-Outcome
genotype -X- _ I-Outcome
prevalence -X- _ I-Outcome
or -X- _ I-Outcome
minor -X- _ I-Outcome
allele -X- _ I-Outcome
frequencies -X- _ I-Outcome
between -X- _ I-Outcome
persons -X- _ I-Outcome
with -X- _ I-Outcome
fatal -X- _ I-Outcome
influenza -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
reference -X- _ I-Outcome
sample. -X- _ I-Outcome
Fatal -X- _ I-Outcome
cases -X- _ I-Outcome
with -X- _ I-Outcome
low-producing -X- _ I-Outcome
MBL2 -X- _ I-Outcome
genotypes -X- _ I-Outcome
had -X- _ I-Outcome
a -X- _ I-Outcome
7-fold -X- _ I-Outcome
increased -X- _ I-Outcome
risk -X- _ I-Outcome
for -X- _ I-Outcome
invasive -X- _ I-Outcome
methicillin-resistant -X- _ I-Outcome
Staphylococcus -X- _ I-Outcome
aureus -X- _ I-Outcome
( -X- _ I-Outcome
MRSA -X- _ I-Outcome
) -X- _ I-Outcome
co-infection -X- _ I-Outcome
compared -X- _ I-Outcome
with -X- _ I-Outcome
fatal -X- _ I-Outcome
cases -X- _ I-Outcome
with -X- _ I-Outcome
high- -X- _ I-Outcome
and -X- _ I-Outcome
intermediate-producing -X- _ I-Outcome
MBL2 -X- _ I-Outcome
genotypes -X- _ I-Outcome
( -X- _ I-Outcome
odds -X- _ I-Outcome
ratio -X- _ I-Outcome
7.1 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
confidence -X- _ I-Outcome
interval -X- _ I-Outcome
1.6â€“32.1 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Limited -X- _ I-Outcome
analysis -X- _ I-Outcome
of -X- _ I-Outcome
2 -X- _ I-Outcome
genes -X- _ I-Outcome
important -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
innate -X- _ I-Outcome
immune -X- _ I-Outcome
response -X- _ I-Outcome
found -X- _ I-Outcome
no -X- _ I-Outcome
association -X- _ I-Outcome
between -X- _ I-Outcome
genetic -X- _ I-Outcome
variants -X- _ I-Outcome
and -X- _ I-Outcome
fatal -X- _ I-Outcome
influenza -X- _ I-Outcome
infection. -X- _ I-Outcome
Among -X- _ O
children -X- _ B-Patient
and -X- _ I-Patient
young -X- _ I-Patient
adults -X- _ I-Patient
who -X- _ I-Patient
died -X- _ I-Patient
of -X- _ I-Patient
influenza -X- _ I-Patient
, -X- _ O
low-producing -X- _ B-Outcome
MBL2 -X- _ I-Outcome
genotypes -X- _ I-Outcome
may -X- _ I-Outcome
have -X- _ I-Outcome
increased -X- _ I-Outcome
risk -X- _ I-Outcome
for -X- _ I-Outcome
MRSA -X- _ I-Outcome
co-infection -X- _ I-Outcome
. -X- _ O

